nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Clonidine—SLC22A4—ulcerative colitis	0.0125	0.513	CrCbGaD
Apraclonidine—Clonidine—SLC22A5—ulcerative colitis	0.00941	0.385	CrCbGaD
Apraclonidine—Clonidine—ABCB1—ulcerative colitis	0.00249	0.102	CrCbGaD
Apraclonidine—Haemorrhage—Methylprednisolone—ulcerative colitis	0.00125	0.00148	CcSEcCtD
Apraclonidine—Pharyngitis—Triamcinolone—ulcerative colitis	0.00124	0.00147	CcSEcCtD
Apraclonidine—Eye disorder—Hydrocortisone—ulcerative colitis	0.00124	0.00147	CcSEcCtD
Apraclonidine—Conjunctivitis—Betamethasone—ulcerative colitis	0.00123	0.00146	CcSEcCtD
Apraclonidine—Conjunctivitis—Dexamethasone—ulcerative colitis	0.00123	0.00146	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisolone—ulcerative colitis	0.00122	0.00144	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.00121	0.00143	CcSEcCtD
Apraclonidine—Visual impairment—Methylprednisolone—ulcerative colitis	0.0012	0.00142	CcSEcCtD
Apraclonidine—Hypersensitivity—Budesonide—ulcerative colitis	0.0012	0.00142	CcSEcCtD
Apraclonidine—Feeling abnormal—Azathioprine—ulcerative colitis	0.0012	0.00142	CcSEcCtD
Apraclonidine—Insomnia—Mesalazine—ulcerative colitis	0.0012	0.00142	CcSEcCtD
Apraclonidine—Paraesthesia—Mesalazine—ulcerative colitis	0.00119	0.00141	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.00119	0.00141	CcSEcCtD
Apraclonidine—Arrhythmia—Hydrocortisone—ulcerative colitis	0.00119	0.00141	CcSEcCtD
Apraclonidine—Erythema—Prednisolone—ulcerative colitis	0.00119	0.0014	CcSEcCtD
Apraclonidine—Dyspnoea—Mesalazine—ulcerative colitis	0.00119	0.0014	CcSEcCtD
Apraclonidine—Somnolence—Mesalazine—ulcerative colitis	0.00118	0.0014	CcSEcCtD
Apraclonidine—Asthenia—Budesonide—ulcerative colitis	0.00117	0.00139	CcSEcCtD
Apraclonidine—Eye disorder—Methylprednisolone—ulcerative colitis	0.00117	0.00138	CcSEcCtD
Apraclonidine—Mental disorder—Hydrocortisone—ulcerative colitis	0.00117	0.00138	CcSEcCtD
Apraclonidine—Erythema—Hydrocortisone—ulcerative colitis	0.00116	0.00137	CcSEcCtD
Apraclonidine—Bradycardia—Dexamethasone—ulcerative colitis	0.00116	0.00137	CcSEcCtD
Apraclonidine—Bradycardia—Betamethasone—ulcerative colitis	0.00116	0.00137	CcSEcCtD
Apraclonidine—Pruritus—Budesonide—ulcerative colitis	0.00116	0.00137	CcSEcCtD
Apraclonidine—Abdominal pain—Azathioprine—ulcerative colitis	0.00115	0.00136	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00115	0.00136	CcSEcCtD
Apraclonidine—Fatigue—Mesalazine—ulcerative colitis	0.00115	0.00136	CcSEcCtD
Apraclonidine—Constipation—Mesalazine—ulcerative colitis	0.00114	0.00134	CcSEcCtD
Apraclonidine—Pain—Mesalazine—ulcerative colitis	0.00114	0.00134	CcSEcCtD
Apraclonidine—Haemorrhage—Dexamethasone—ulcerative colitis	0.00114	0.00134	CcSEcCtD
Apraclonidine—Haemorrhage—Betamethasone—ulcerative colitis	0.00114	0.00134	CcSEcCtD
Apraclonidine—Angiopathy—Methylprednisolone—ulcerative colitis	0.00113	0.00134	CcSEcCtD
Apraclonidine—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.00113	0.00133	CcSEcCtD
Apraclonidine—Arrhythmia—Triamcinolone—ulcerative colitis	0.00112	0.00132	CcSEcCtD
Apraclonidine—Diarrhoea—Budesonide—ulcerative colitis	0.00112	0.00132	CcSEcCtD
Apraclonidine—Vision blurred—Prednisolone—ulcerative colitis	0.00112	0.00132	CcSEcCtD
Apraclonidine—Arrhythmia—Methylprednisolone—ulcerative colitis	0.00112	0.00132	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisolone—ulcerative colitis	0.0011	0.0013	CcSEcCtD
Apraclonidine—Visual impairment—Dexamethasone—ulcerative colitis	0.0011	0.0013	CcSEcCtD
Apraclonidine—Visual impairment—Betamethasone—ulcerative colitis	0.0011	0.0013	CcSEcCtD
Apraclonidine—Feeling abnormal—Mesalazine—ulcerative colitis	0.0011	0.0013	CcSEcCtD
Apraclonidine—Mental disorder—Methylprednisolone—ulcerative colitis	0.0011	0.0013	CcSEcCtD
Apraclonidine—Erythema—Triamcinolone—ulcerative colitis	0.00109	0.00129	CcSEcCtD
Apraclonidine—Erythema—Methylprednisolone—ulcerative colitis	0.00109	0.00129	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00109	0.00129	CcSEcCtD
Apraclonidine—Dizziness—Budesonide—ulcerative colitis	0.00108	0.00128	CcSEcCtD
Apraclonidine—Hypersensitivity—Azathioprine—ulcerative colitis	0.00108	0.00127	CcSEcCtD
Apraclonidine—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.00107	0.00127	CcSEcCtD
Apraclonidine—Malaise—Prednisolone—ulcerative colitis	0.00107	0.00126	CcSEcCtD
Apraclonidine—Dysgeusia—Triamcinolone—ulcerative colitis	0.00107	0.00126	CcSEcCtD
Apraclonidine—Syncope—Prednisolone—ulcerative colitis	0.00106	0.00126	CcSEcCtD
Apraclonidine—Eye disorder—Dexamethasone—ulcerative colitis	0.00106	0.00126	CcSEcCtD
Apraclonidine—Eye disorder—Betamethasone—ulcerative colitis	0.00106	0.00126	CcSEcCtD
Apraclonidine—Abdominal pain—Mesalazine—ulcerative colitis	0.00105	0.00124	CcSEcCtD
Apraclonidine—Malaise—Hydrocortisone—ulcerative colitis	0.00104	0.00124	CcSEcCtD
Apraclonidine—Vomiting—Budesonide—ulcerative colitis	0.00104	0.00123	CcSEcCtD
Apraclonidine—Syncope—Hydrocortisone—ulcerative colitis	0.00104	0.00123	CcSEcCtD
Apraclonidine—Angiopathy—Dexamethasone—ulcerative colitis	0.00103	0.00122	CcSEcCtD
Apraclonidine—Angiopathy—Betamethasone—ulcerative colitis	0.00103	0.00122	CcSEcCtD
Apraclonidine—Dermatitis—Budesonide—ulcerative colitis	0.00103	0.00122	CcSEcCtD
Apraclonidine—Headache—Budesonide—ulcerative colitis	0.00102	0.00121	CcSEcCtD
Apraclonidine—Arrhythmia—Dexamethasone—ulcerative colitis	0.00102	0.0012	CcSEcCtD
Apraclonidine—Arrhythmia—Betamethasone—ulcerative colitis	0.00102	0.0012	CcSEcCtD
Apraclonidine—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.00101	0.0012	CcSEcCtD
Apraclonidine—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.00101	0.00119	CcSEcCtD
Apraclonidine—Bradycardia—Prednisone—ulcerative colitis	0.00101	0.00119	CcSEcCtD
Apraclonidine—Diarrhoea—Azathioprine—ulcerative colitis	0.000999	0.00118	CcSEcCtD
Apraclonidine—Discomfort—Prednisolone—ulcerative colitis	0.000998	0.00118	CcSEcCtD
Apraclonidine—Haemorrhage—Prednisone—ulcerative colitis	0.00099	0.00117	CcSEcCtD
Apraclonidine—Erythema—Betamethasone—ulcerative colitis	0.00099	0.00117	CcSEcCtD
Apraclonidine—Erythema—Dexamethasone—ulcerative colitis	0.00099	0.00117	CcSEcCtD
Apraclonidine—Myalgia—Hydrocortisone—ulcerative colitis	0.000986	0.00117	CcSEcCtD
Apraclonidine—Malaise—Triamcinolone—ulcerative colitis	0.000984	0.00116	CcSEcCtD
Apraclonidine—Malaise—Methylprednisolone—ulcerative colitis	0.000981	0.00116	CcSEcCtD
Apraclonidine—Hypersensitivity—Mesalazine—ulcerative colitis	0.00098	0.00116	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000979	0.00116	CcSEcCtD
Apraclonidine—Syncope—Triamcinolone—ulcerative colitis	0.000978	0.00116	CcSEcCtD
Apraclonidine—Syncope—Methylprednisolone—ulcerative colitis	0.000976	0.00115	CcSEcCtD
Apraclonidine—Discomfort—Hydrocortisone—ulcerative colitis	0.000974	0.00115	CcSEcCtD
Apraclonidine—Nausea—Budesonide—ulcerative colitis	0.000971	0.00115	CcSEcCtD
Apraclonidine—Oedema—Prednisolone—ulcerative colitis	0.000968	0.00114	CcSEcCtD
Apraclonidine—Dizziness—Azathioprine—ulcerative colitis	0.000965	0.00114	CcSEcCtD
Apraclonidine—Asthenia—Mesalazine—ulcerative colitis	0.000954	0.00113	CcSEcCtD
Apraclonidine—Oedema—Hydrocortisone—ulcerative colitis	0.000945	0.00112	CcSEcCtD
Apraclonidine—Pruritus—Mesalazine—ulcerative colitis	0.000941	0.00111	CcSEcCtD
Apraclonidine—Infection—Hydrocortisone—ulcerative colitis	0.000939	0.00111	CcSEcCtD
Apraclonidine—Myalgia—Triamcinolone—ulcerative colitis	0.000929	0.0011	CcSEcCtD
Apraclonidine—Vomiting—Azathioprine—ulcerative colitis	0.000928	0.0011	CcSEcCtD
Apraclonidine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000927	0.0011	CcSEcCtD
Apraclonidine—Myalgia—Methylprednisolone—ulcerative colitis	0.000927	0.0011	CcSEcCtD
Apraclonidine—Eye disorder—Prednisone—ulcerative colitis	0.000925	0.00109	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00092	0.00109	CcSEcCtD
Apraclonidine—Dermatitis—Azathioprine—ulcerative colitis	0.000919	0.00109	CcSEcCtD
Apraclonidine—Skin disorder—Hydrocortisone—ulcerative colitis	0.000918	0.00109	CcSEcCtD
Apraclonidine—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000918	0.00109	CcSEcCtD
Apraclonidine—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000918	0.00109	CcSEcCtD
Apraclonidine—Discomfort—Triamcinolone—ulcerative colitis	0.000918	0.00108	CcSEcCtD
Apraclonidine—Discomfort—Methylprednisolone—ulcerative colitis	0.000916	0.00108	CcSEcCtD
Apraclonidine—Headache—Azathioprine—ulcerative colitis	0.000914	0.00108	CcSEcCtD
Apraclonidine—Diarrhoea—Mesalazine—ulcerative colitis	0.00091	0.00108	CcSEcCtD
Apraclonidine—Dry mouth—Triamcinolone—ulcerative colitis	0.000908	0.00107	CcSEcCtD
Apraclonidine—Angiopathy—Prednisone—ulcerative colitis	0.000898	0.00106	CcSEcCtD
Apraclonidine—Malaise—Dexamethasone—ulcerative colitis	0.000893	0.00106	CcSEcCtD
Apraclonidine—Malaise—Betamethasone—ulcerative colitis	0.000893	0.00106	CcSEcCtD
Apraclonidine—Oedema—Triamcinolone—ulcerative colitis	0.00089	0.00105	CcSEcCtD
Apraclonidine—Syncope—Dexamethasone—ulcerative colitis	0.000888	0.00105	CcSEcCtD
Apraclonidine—Syncope—Betamethasone—ulcerative colitis	0.000888	0.00105	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisone—ulcerative colitis	0.000885	0.00105	CcSEcCtD
Apraclonidine—Infection—Triamcinolone—ulcerative colitis	0.000884	0.00105	CcSEcCtD
Apraclonidine—Infection—Methylprednisolone—ulcerative colitis	0.000882	0.00104	CcSEcCtD
Apraclonidine—Dizziness—Mesalazine—ulcerative colitis	0.000879	0.00104	CcSEcCtD
Apraclonidine—Insomnia—Prednisolone—ulcerative colitis	0.000876	0.00104	CcSEcCtD
Apraclonidine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000871	0.00103	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisolone—ulcerative colitis	0.000869	0.00103	CcSEcCtD
Apraclonidine—Mental disorder—Prednisone—ulcerative colitis	0.000867	0.00103	CcSEcCtD
Apraclonidine—Nausea—Azathioprine—ulcerative colitis	0.000867	0.00103	CcSEcCtD
Apraclonidine—Skin disorder—Methylprednisolone—ulcerative colitis	0.000863	0.00102	CcSEcCtD
Apraclonidine—Erythema—Prednisone—ulcerative colitis	0.000862	0.00102	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000861	0.00102	CcSEcCtD
Apraclonidine—Insomnia—Hydrocortisone—ulcerative colitis	0.000855	0.00101	CcSEcCtD
Apraclonidine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000849	0.001	CcSEcCtD
Apraclonidine—Vomiting—Mesalazine—ulcerative colitis	0.000845	0.001	CcSEcCtD
Apraclonidine—Myalgia—Betamethasone—ulcerative colitis	0.000843	0.000996	CcSEcCtD
Apraclonidine—Myalgia—Dexamethasone—ulcerative colitis	0.000843	0.000996	CcSEcCtD
Apraclonidine—Dermatitis—Mesalazine—ulcerative colitis	0.000838	0.00099	CcSEcCtD
Apraclonidine—Headache—Mesalazine—ulcerative colitis	0.000833	0.000985	CcSEcCtD
Apraclonidine—Discomfort—Dexamethasone—ulcerative colitis	0.000833	0.000984	CcSEcCtD
Apraclonidine—Discomfort—Betamethasone—ulcerative colitis	0.000833	0.000984	CcSEcCtD
Apraclonidine—Pain—Prednisolone—ulcerative colitis	0.000828	0.000979	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000816	0.000965	CcSEcCtD
Apraclonidine—Fatigue—Hydrocortisone—ulcerative colitis	0.000815	0.000964	CcSEcCtD
Apraclonidine—Vision blurred—Prednisone—ulcerative colitis	0.000812	0.000961	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000811	0.000959	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000809	0.000957	CcSEcCtD
Apraclonidine—Pain—Hydrocortisone—ulcerative colitis	0.000809	0.000956	CcSEcCtD
Apraclonidine—Oedema—Dexamethasone—ulcerative colitis	0.000808	0.000955	CcSEcCtD
Apraclonidine—Oedema—Betamethasone—ulcerative colitis	0.000808	0.000955	CcSEcCtD
Apraclonidine—Insomnia—Triamcinolone—ulcerative colitis	0.000805	0.000952	CcSEcCtD
Apraclonidine—Insomnia—Methylprednisolone—ulcerative colitis	0.000803	0.00095	CcSEcCtD
Apraclonidine—Infection—Betamethasone—ulcerative colitis	0.000802	0.000949	CcSEcCtD
Apraclonidine—Infection—Dexamethasone—ulcerative colitis	0.000802	0.000949	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisone—ulcerative colitis	0.0008	0.000946	CcSEcCtD
Apraclonidine—Paraesthesia—Triamcinolone—ulcerative colitis	0.000799	0.000945	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisolone—ulcerative colitis	0.000798	0.000943	CcSEcCtD
Apraclonidine—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000798	0.000943	CcSEcCtD
Apraclonidine—Dyspnoea—Triamcinolone—ulcerative colitis	0.000794	0.000939	CcSEcCtD
Apraclonidine—Nervous system disorder—Betamethasone—ulcerative colitis	0.000792	0.000937	CcSEcCtD
Apraclonidine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000792	0.000937	CcSEcCtD
Apraclonidine—Nausea—Mesalazine—ulcerative colitis	0.00079	0.000934	CcSEcCtD
Apraclonidine—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000779	0.000921	CcSEcCtD
Apraclonidine—Malaise—Prednisone—ulcerative colitis	0.000777	0.000919	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000773	0.000914	CcSEcCtD
Apraclonidine—Syncope—Prednisone—ulcerative colitis	0.000773	0.000914	CcSEcCtD
Apraclonidine—Fatigue—Triamcinolone—ulcerative colitis	0.000768	0.000908	CcSEcCtD
Apraclonidine—Fatigue—Methylprednisolone—ulcerative colitis	0.000766	0.000906	CcSEcCtD
Apraclonidine—Pain—Triamcinolone—ulcerative colitis	0.000761	0.0009	CcSEcCtD
Apraclonidine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000747	0.000884	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000736	0.00087	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000736	0.00087	CcSEcCtD
Apraclonidine—Myalgia—Prednisone—ulcerative colitis	0.000734	0.000868	CcSEcCtD
Apraclonidine—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000734	0.000867	CcSEcCtD
Apraclonidine—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000732	0.000866	CcSEcCtD
Apraclonidine—Insomnia—Dexamethasone—ulcerative colitis	0.000731	0.000864	CcSEcCtD
Apraclonidine—Insomnia—Betamethasone—ulcerative colitis	0.000731	0.000864	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000729	0.000862	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000726	0.000859	CcSEcCtD
Apraclonidine—Paraesthesia—Betamethasone—ulcerative colitis	0.000725	0.000858	CcSEcCtD
Apraclonidine—Paraesthesia—Dexamethasone—ulcerative colitis	0.000725	0.000858	CcSEcCtD
Apraclonidine—Discomfort—Prednisone—ulcerative colitis	0.000725	0.000857	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisolone—ulcerative colitis	0.000713	0.000843	CcSEcCtD
Apraclonidine—Oedema—Prednisone—ulcerative colitis	0.000703	0.000832	CcSEcCtD
Apraclonidine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000702	0.00083	CcSEcCtD
Apraclonidine—Infection—Prednisone—ulcerative colitis	0.000699	0.000826	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000697	0.000825	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000697	0.000825	CcSEcCtD
Apraclonidine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000697	0.000824	CcSEcCtD
Apraclonidine—Fatigue—Dexamethasone—ulcerative colitis	0.000696	0.000824	CcSEcCtD
Apraclonidine—Fatigue—Betamethasone—ulcerative colitis	0.000696	0.000824	CcSEcCtD
Apraclonidine—Pain—Dexamethasone—ulcerative colitis	0.000691	0.000817	CcSEcCtD
Apraclonidine—Pain—Betamethasone—ulcerative colitis	0.000691	0.000817	CcSEcCtD
Apraclonidine—Nervous system disorder—Prednisone—ulcerative colitis	0.00069	0.000816	CcSEcCtD
Apraclonidine—Skin disorder—Prednisone—ulcerative colitis	0.000683	0.000808	CcSEcCtD
Apraclonidine—Asthenia—Hydrocortisone—ulcerative colitis	0.000678	0.000802	CcSEcCtD
Apraclonidine—Pruritus—Hydrocortisone—ulcerative colitis	0.000669	0.000791	CcSEcCtD
Apraclonidine—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000666	0.000787	CcSEcCtD
Apraclonidine—Feeling abnormal—Betamethasone—ulcerative colitis	0.000666	0.000787	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000661	0.000781	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000661	0.000781	CcSEcCtD
Apraclonidine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000656	0.000776	CcSEcCtD
Apraclonidine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000654	0.000774	CcSEcCtD
Apraclonidine—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000647	0.000765	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000641	0.000758	CcSEcCtD
Apraclonidine—Dizziness—Prednisolone—ulcerative colitis	0.00064	0.000757	CcSEcCtD
Apraclonidine—Asthenia—Triamcinolone—ulcerative colitis	0.000639	0.000755	CcSEcCtD
Apraclonidine—Abdominal pain—Betamethasone—ulcerative colitis	0.000639	0.000755	CcSEcCtD
Apraclonidine—Abdominal pain—Dexamethasone—ulcerative colitis	0.000639	0.000755	CcSEcCtD
Apraclonidine—Asthenia—Methylprednisolone—ulcerative colitis	0.000637	0.000754	CcSEcCtD
Apraclonidine—Insomnia—Prednisone—ulcerative colitis	0.000636	0.000752	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisone—ulcerative colitis	0.000632	0.000747	CcSEcCtD
Apraclonidine—Pruritus—Triamcinolone—ulcerative colitis	0.00063	0.000745	CcSEcCtD
Apraclonidine—Pruritus—Methylprednisolone—ulcerative colitis	0.000628	0.000743	CcSEcCtD
Apraclonidine—Dizziness—Hydrocortisone—ulcerative colitis	0.000625	0.000739	CcSEcCtD
Apraclonidine—Dermatitis—Prednisolone—ulcerative colitis	0.00061	0.000721	CcSEcCtD
Apraclonidine—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000608	0.000719	CcSEcCtD
Apraclonidine—Fatigue—Prednisone—ulcerative colitis	0.000606	0.000717	CcSEcCtD
Apraclonidine—Headache—Prednisolone—ulcerative colitis	0.000606	0.000717	CcSEcCtD
Apraclonidine—Constipation—Prednisone—ulcerative colitis	0.000602	0.000711	CcSEcCtD
Apraclonidine—Vomiting—Hydrocortisone—ulcerative colitis	0.000601	0.000711	CcSEcCtD
Apraclonidine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000596	0.000704	CcSEcCtD
Apraclonidine—Headache—Hydrocortisone—ulcerative colitis	0.000592	0.0007	CcSEcCtD
Apraclonidine—Dizziness—Triamcinolone—ulcerative colitis	0.000589	0.000696	CcSEcCtD
Apraclonidine—Dizziness—Methylprednisolone—ulcerative colitis	0.000587	0.000695	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisone—ulcerative colitis	0.00058	0.000685	CcSEcCtD
Apraclonidine—Asthenia—Betamethasone—ulcerative colitis	0.00058	0.000685	CcSEcCtD
Apraclonidine—Asthenia—Dexamethasone—ulcerative colitis	0.00058	0.000685	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000575	0.00068	CcSEcCtD
Apraclonidine—Nausea—Prednisolone—ulcerative colitis	0.000575	0.00068	CcSEcCtD
Apraclonidine—Pruritus—Betamethasone—ulcerative colitis	0.000571	0.000676	CcSEcCtD
Apraclonidine—Pruritus—Dexamethasone—ulcerative colitis	0.000571	0.000676	CcSEcCtD
Apraclonidine—Vomiting—Triamcinolone—ulcerative colitis	0.000566	0.000669	CcSEcCtD
Apraclonidine—Vomiting—Methylprednisolone—ulcerative colitis	0.000565	0.000668	CcSEcCtD
Apraclonidine—Nausea—Hydrocortisone—ulcerative colitis	0.000562	0.000664	CcSEcCtD
Apraclonidine—Dermatitis—Triamcinolone—ulcerative colitis	0.000561	0.000663	CcSEcCtD
Apraclonidine—Dermatitis—Methylprednisolone—ulcerative colitis	0.00056	0.000662	CcSEcCtD
Apraclonidine—Headache—Triamcinolone—ulcerative colitis	0.000558	0.000659	CcSEcCtD
Apraclonidine—Headache—Methylprednisolone—ulcerative colitis	0.000556	0.000658	CcSEcCtD
Apraclonidine—Abdominal pain—Prednisone—ulcerative colitis	0.000556	0.000658	CcSEcCtD
Apraclonidine—Diarrhoea—Dexamethasone—ulcerative colitis	0.000553	0.000654	CcSEcCtD
Apraclonidine—Diarrhoea—Betamethasone—ulcerative colitis	0.000553	0.000654	CcSEcCtD
Apraclonidine—Dizziness—Dexamethasone—ulcerative colitis	0.000534	0.000632	CcSEcCtD
Apraclonidine—Dizziness—Betamethasone—ulcerative colitis	0.000534	0.000632	CcSEcCtD
Apraclonidine—Nausea—Triamcinolone—ulcerative colitis	0.000529	0.000625	CcSEcCtD
Apraclonidine—Nausea—Methylprednisolone—ulcerative colitis	0.000528	0.000624	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisone—ulcerative colitis	0.000518	0.000613	CcSEcCtD
Apraclonidine—Vomiting—Dexamethasone—ulcerative colitis	0.000514	0.000607	CcSEcCtD
Apraclonidine—Vomiting—Betamethasone—ulcerative colitis	0.000514	0.000607	CcSEcCtD
Apraclonidine—Dermatitis—Dexamethasone—ulcerative colitis	0.000509	0.000602	CcSEcCtD
Apraclonidine—Dermatitis—Betamethasone—ulcerative colitis	0.000509	0.000602	CcSEcCtD
Apraclonidine—Headache—Dexamethasone—ulcerative colitis	0.000506	0.000598	CcSEcCtD
Apraclonidine—Headache—Betamethasone—ulcerative colitis	0.000506	0.000598	CcSEcCtD
Apraclonidine—Asthenia—Prednisone—ulcerative colitis	0.000505	0.000597	CcSEcCtD
Apraclonidine—Pruritus—Prednisone—ulcerative colitis	0.000498	0.000589	CcSEcCtD
Apraclonidine—Diarrhoea—Prednisone—ulcerative colitis	0.000481	0.000569	CcSEcCtD
Apraclonidine—Nausea—Dexamethasone—ulcerative colitis	0.00048	0.000567	CcSEcCtD
Apraclonidine—Nausea—Betamethasone—ulcerative colitis	0.00048	0.000567	CcSEcCtD
Apraclonidine—Dizziness—Prednisone—ulcerative colitis	0.000465	0.00055	CcSEcCtD
Apraclonidine—Vomiting—Prednisone—ulcerative colitis	0.000447	0.000529	CcSEcCtD
Apraclonidine—Dermatitis—Prednisone—ulcerative colitis	0.000443	0.000524	CcSEcCtD
Apraclonidine—Headache—Prednisone—ulcerative colitis	0.000441	0.000521	CcSEcCtD
Apraclonidine—Nausea—Prednisone—ulcerative colitis	0.000418	0.000494	CcSEcCtD
Apraclonidine—ADRA2B—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000227	0.00174	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCL20—ulcerative colitis	0.000227	0.00174	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—GHRL—ulcerative colitis	0.000226	0.00174	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—DLD—ulcerative colitis	0.000225	0.00173	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000222	0.00171	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—GNA12—ulcerative colitis	0.000219	0.00169	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000216	0.00166	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—GNA12—ulcerative colitis	0.000213	0.00164	CbGpPWpGaD
Apraclonidine—ADRA2C—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000212	0.00163	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL20—ulcerative colitis	0.000212	0.00163	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CHP1—ulcerative colitis	0.000211	0.00163	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000211	0.00162	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CCR6—ulcerative colitis	0.000209	0.00161	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000208	0.0016	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCL20—ulcerative colitis	0.000204	0.00157	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCR2—ulcerative colitis	0.000202	0.00155	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—ADRB2—ulcerative colitis	0.000202	0.00155	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—GNA12—ulcerative colitis	0.000199	0.00153	CbGpPWpGaD
Apraclonidine—ADRA2B—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	0.000198	0.00152	CbGpPWpGaD
Apraclonidine—ADRA2B—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000197	0.00152	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—CALM3—ulcerative colitis	0.000196	0.00151	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000196	0.00151	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CCR6—ulcerative colitis	0.000195	0.0015	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—GNA12—ulcerative colitis	0.000192	0.00147	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCR6—ulcerative colitis	0.00019	0.00146	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCL20—ulcerative colitis	0.000189	0.00146	CbGpPWpGaD
Apraclonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000189	0.00146	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCR2—ulcerative colitis	0.000189	0.00145	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—ADRB2—ulcerative colitis	0.000187	0.00144	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SEL1L—ulcerative colitis	0.000185	0.00142	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL20—ulcerative colitis	0.000185	0.00142	CbGpPWpGaD
Apraclonidine—ADRA2A—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	0.000185	0.00142	CbGpPWpGaD
Apraclonidine—ADRA2C—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	0.000185	0.00142	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000184	0.00142	CbGpPWpGaD
Apraclonidine—ADRA2C—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000184	0.00142	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—DLD—ulcerative colitis	0.000182	0.0014	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000182	0.0014	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—GNA12—ulcerative colitis	0.000178	0.00137	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCR6—ulcerative colitis	0.000177	0.00137	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—GNA12—ulcerative colitis	0.000174	0.00134	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SEL1L—ulcerative colitis	0.000173	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000172	0.00132	CbGpPWpGaD
Apraclonidine—ADRA2A—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000172	0.00132	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL20—ulcerative colitis	0.000172	0.00132	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCR6—ulcerative colitis	0.000171	0.00131	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000169	0.0013	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—GHRL—ulcerative colitis	0.000168	0.0013	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—PTGER4—ulcerative colitis	0.000167	0.00129	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—MMP1—ulcerative colitis	0.000166	0.00128	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCR2—ulcerative colitis	0.000165	0.00127	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—GNA12—ulcerative colitis	0.000162	0.00124	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCR6—ulcerative colitis	0.000159	0.00122	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—GHRL—ulcerative colitis	0.000157	0.00121	CbGpPWpGaD
Apraclonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000157	0.00121	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—PTGER4—ulcerative colitis	0.000156	0.0012	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCR6—ulcerative colitis	0.000155	0.00119	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—MMP1—ulcerative colitis	0.000155	0.00119	CbGpPWpGaD
Apraclonidine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000154	0.00119	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCR2—ulcerative colitis	0.000153	0.00118	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—GHRL—ulcerative colitis	0.000153	0.00118	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCR1—ulcerative colitis	0.000152	0.00117	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SEL1L—ulcerative colitis	0.000151	0.00116	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00015	0.00116	CbGpPWpGaD
Apraclonidine—ADRA2A—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	0.00015	0.00115	CbGpPWpGaD
Apraclonidine—ADRA2A—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000149	0.00115	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CALM3—ulcerative colitis	0.000148	0.00114	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000146	0.00113	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCR6—ulcerative colitis	0.000144	0.00111	CbGpPWpGaD
Apraclonidine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000144	0.00111	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—GHRL—ulcerative colitis	0.000143	0.0011	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCR1—ulcerative colitis	0.000142	0.0011	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SEL1L—ulcerative colitis	0.00014	0.00108	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00014	0.00107	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000139	0.00107	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CALM3—ulcerative colitis	0.000138	0.00107	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—GHRL—ulcerative colitis	0.000138	0.00106	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—PTGER4—ulcerative colitis	0.000136	0.00105	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL20—ulcerative colitis	0.000134	0.00103	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00013	0.001	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—GHRL—ulcerative colitis	0.000128	0.000984	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000128	0.000984	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PTGER4—ulcerative colitis	0.000127	0.000976	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—ADRB2—ulcerative colitis	0.000127	0.000975	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—GNA12—ulcerative colitis	0.000126	0.000969	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—MMP1—ulcerative colitis	0.000126	0.000968	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—ALB—ulcerative colitis	0.000126	0.000967	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL20—ulcerative colitis	0.000125	0.000962	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—GHRL—ulcerative colitis	0.000125	0.000962	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCR1—ulcerative colitis	0.000124	0.000958	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CALM3—ulcerative colitis	0.000121	0.000932	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCR2—ulcerative colitis	0.000119	0.000918	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—CXCL8—ulcerative colitis	0.000119	0.000918	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000119	0.000914	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000118	0.000911	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—ADRB2—ulcerative colitis	0.000118	0.000911	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GNA12—ulcerative colitis	0.000118	0.000905	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—ALB—ulcerative colitis	0.000117	0.000903	CbGpPWpGaD
Apraclonidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000117	0.0009	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—JAK2—ulcerative colitis	0.000117	0.000899	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—GHRL—ulcerative colitis	0.000116	0.000894	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCR1—ulcerative colitis	0.000116	0.00089	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000114	0.000877	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CALM3—ulcerative colitis	0.000112	0.000866	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCR6—ulcerative colitis	0.000112	0.000863	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCR2—ulcerative colitis	0.000111	0.000858	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—CXCL8—ulcerative colitis	0.000111	0.000857	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000111	0.000851	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	0.000109	0.000841	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—JAK2—ulcerative colitis	0.000109	0.00084	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PTGS1—ulcerative colitis	0.000109	0.000836	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—ADCY5—ulcerative colitis	0.000108	0.000828	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MAML2—ulcerative colitis	0.000106	0.000818	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000106	0.000815	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCR6—ulcerative colitis	0.000105	0.000806	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	0.000103	0.000796	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	0.000103	0.000791	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—IL2—ulcerative colitis	0.000102	0.000784	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	0.000102	0.000782	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—ADCY5—ulcerative colitis	0.0001	0.000773	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MAML2—ulcerative colitis	9.93e-05	0.000764	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PTGER4—ulcerative colitis	9.87e-05	0.00076	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CALM3—ulcerative colitis	9.78e-05	0.000753	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	9.74e-05	0.00075	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	9.73e-05	0.000749	CbGpPWpGaD
Apraclonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	9.7e-05	0.000746	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	9.67e-05	0.000744	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	9.61e-05	0.00074	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	9.55e-05	0.000735	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—ALB—ulcerative colitis	9.53e-05	0.000734	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—IL2—ulcerative colitis	9.51e-05	0.000733	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PTGER4—ulcerative colitis	9.22e-05	0.00071	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	9.16e-05	0.000705	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	9.05e-05	0.000697	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	9.04e-05	0.000696	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—GHRL—ulcerative colitis	9.04e-05	0.000696	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	8.98e-05	0.000692	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—JAK2—ulcerative colitis	8.86e-05	0.000682	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PTGS1—ulcerative colitis	8.82e-05	0.000679	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	8.78e-05	0.000676	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CALM3—ulcerative colitis	8.75e-05	0.000674	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	8.68e-05	0.000668	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—RIPK2—ulcerative colitis	8.62e-05	0.000664	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	8.51e-05	0.000655	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GHRL—ulcerative colitis	8.44e-05	0.00065	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CALM3—ulcerative colitis	8.18e-05	0.00063	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	8.16e-05	0.000628	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	8.07e-05	0.000621	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	8.06e-05	0.000621	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—RIPK2—ulcerative colitis	8.05e-05	0.00062	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—TGFB1—ulcerative colitis	7.95e-05	0.000612	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CALM3—ulcerative colitis	7.94e-05	0.000612	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IL2—ulcerative colitis	7.73e-05	0.000595	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ABCB1—ulcerative colitis	7.6e-05	0.000585	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	7.49e-05	0.000577	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ADRB2—ulcerative colitis	7.48e-05	0.000576	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—TGFB1—ulcerative colitis	7.42e-05	0.000571	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	7.38e-05	0.000568	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—JAK2—ulcerative colitis	7.38e-05	0.000568	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	7.15e-05	0.00055	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ADCY5—ulcerative colitis	7.09e-05	0.000546	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	7.04e-05	0.000542	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ADRB2—ulcerative colitis	6.99e-05	0.000538	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—JAK2—ulcerative colitis	6.89e-05	0.000531	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	6.86e-05	0.000528	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CXCL8—ulcerative colitis	6.74e-05	0.000519	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—JAK2—ulcerative colitis	6.7e-05	0.000516	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	6.64e-05	0.000511	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	6.54e-05	0.000504	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—TP53—ulcerative colitis	6.54e-05	0.000504	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—IL2—ulcerative colitis	6.44e-05	0.000496	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ADCY5—ulcerative colitis	6.35e-05	0.000489	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCL8—ulcerative colitis	6.29e-05	0.000484	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—JAK2—ulcerative colitis	6.26e-05	0.000482	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ABCB1—ulcerative colitis	6.18e-05	0.000476	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	6.12e-05	0.000471	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—TP53—ulcerative colitis	6.11e-05	0.00047	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	6.11e-05	0.00047	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	6.03e-05	0.000464	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	6.03e-05	0.000464	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—IL2—ulcerative colitis	6.01e-05	0.000463	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ADCY5—ulcerative colitis	5.93e-05	0.000457	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	5.85e-05	0.00045	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ADCY5—ulcerative colitis	5.76e-05	0.000444	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCL8—ulcerative colitis	5.71e-05	0.00044	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	5.68e-05	0.000437	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	5.6e-05	0.000431	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	5.5e-05	0.000423	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	5.47e-05	0.000421	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL2—ulcerative colitis	5.46e-05	0.00042	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PPARG—ulcerative colitis	5.29e-05	0.000407	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	5.26e-05	0.000405	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	5.19e-05	0.000399	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	5.11e-05	0.000393	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	5.08e-05	0.000391	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	4.99e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—TP53—ulcerative colitis	4.96e-05	0.000382	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	4.88e-05	0.000376	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	4.82e-05	0.000371	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	4.77e-05	0.000368	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ALB—ulcerative colitis	4.76e-05	0.000366	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	4.64e-05	0.000357	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	4.44e-05	0.000341	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PPARG—ulcerative colitis	4.3e-05	0.000331	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PTGS2—ulcerative colitis	4.16e-05	0.00032	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	3.96e-05	0.000305	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ALB—ulcerative colitis	3.86e-05	0.000298	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	3.83e-05	0.000295	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	3.7e-05	0.000285	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	3.61e-05	0.000278	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	3.58e-05	0.000276	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	3.45e-05	0.000266	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	3.44e-05	0.000265	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PTGS2—ulcerative colitis	3.38e-05	0.00026	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	3.38e-05	0.00026	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	3.27e-05	0.000252	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	3.23e-05	0.000249	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	3.23e-05	0.000249	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	3.23e-05	0.000248	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	3.21e-05	0.000247	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	3.13e-05	0.000241	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	3.05e-05	0.000235	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	3.02e-05	0.000233	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	3e-05	0.000231	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	2.95e-05	0.000227	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	2.91e-05	0.000224	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	2.91e-05	0.000224	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	2.82e-05	0.000217	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	2.81e-05	0.000216	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	2.74e-05	0.000211	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	2.71e-05	0.000209	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	2.69e-05	0.000207	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	2.67e-05	0.000205	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	2.64e-05	0.000203	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	2.62e-05	0.000202	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	2.61e-05	0.000201	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	2.52e-05	0.000194	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	2.48e-05	0.000191	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	2.45e-05	0.000189	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	2.37e-05	0.000183	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	2.22e-05	0.000171	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	2.2e-05	0.00017	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	2.2e-05	0.000169	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	2.07e-05	0.000159	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	2.04e-05	0.000157	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	2.03e-05	0.000156	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	1.9e-05	0.000146	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	1.81e-05	0.000139	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	1.68e-05	0.00013	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	1.66e-05	0.000128	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	1.54e-05	0.000119	CbGpPWpGaD
